Brnabic A - Search Results

1

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses.

Warren RB, See K, Burge R, Zhang Y, Brnabic A, Gallo G, Garrelts A, Egeberg A. Warren RB, et al. Among authors: brnabic a. Dermatol Ther (Heidelb). 2020 Feb;10(1):73-86. doi: 10.1007/s13555-019-00337-y. Epub 2019 Nov 4. Dermatol Ther (Heidelb). 2020. PMID: 31686337 Free PMC article.

2

Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis.

Warren RB, Gooderham M, Burge R, Zhu B, Amato D, Liu KH, Shrom D, Guo J, Brnabic A, Blauvelt A. Warren RB, et al. Among authors: brnabic a. J Am Acad Dermatol. 2020 May;82(5):1138-1149. doi: 10.1016/j.jaad.2019.12.038. Epub 2019 Dec 26. J Am Acad Dermatol. 2020. PMID: 31884091 Free article.

3

Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review.

Blauvelt A, Burge R, Malatestinic W, Brnabic A, Guo J, Janardhanan M, Zhu B. Blauvelt A, et al. Among authors: brnabic a. J Manag Care Spec Pharm. 2021 Jan;27(1):84-94. doi: 10.18553/jmcp.2021.27.1.084. J Manag Care Spec Pharm. 2021. PMID: 33377444 Free PMC article.

Assessing the cost of biologics relative to their cumulative clinical benefits versus a single time point represents an alternative to evaluate the value of a given biologic used to treat psoriasis. ...Burge, Zhu, Malatestinic, Brnabic, Guo, and Janardhanan a …

Assessing the cost of biologics relative to their cumulative clinical benefits versus a single time point represents an alternative t …

4

Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab.

Warren RB, Brnabic A, Saure D, Langley RG, See K, Wu JJ, Schacht A, Mallbris L, Nast A. Warren RB, et al. Among authors: brnabic a. Br J Dermatol. 2018 May;178(5):1064-1071. doi: 10.1111/bjd.16140. Epub 2018 Mar 1. Br J Dermatol. 2018. PMID: 29171861

5

Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate-to-severe genital psoriasis.

Merola JF, Ghislain PD, Dauendorffer JN, Potts Bleakman A, Brnabic AJM, Burge R, Riedl E. Merola JF, et al. Among authors: brnabic ajm. J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1257-1262. doi: 10.1111/jdv.16181. Epub 2020 Feb 5. J Eur Acad Dermatol Venereol. 2020. PMID: 31919919 Free PMC article. Clinical Trial.

6

Burden of Disease for Psoriasis in Argentina, Brazil, Colombia, and Mexico.

Papadimitropoulos E, Romiti R, Haro JM, Brnabic A, Gómez-Martín D, Firmino Goncalves L, Burge R. Papadimitropoulos E, et al. Among authors: brnabic a. Value Health Reg Issues. 2021 Dec;26:126-134. doi: 10.1016/j.vhri.2021.05.004. Epub 2021 Jul 31. Value Health Reg Issues. 2021. PMID: 34343848 Free article.

7

Lifestyle-Related Metabolic Disorders, Osteoporosis, and Fracture Risk in Asia: A Systematic Review.

Sugimoto T, Sato M, Dehle FC, Brnabic AJ, Weston A, Burge R. Sugimoto T, et al. Among authors: brnabic aj. Value Health Reg Issues. 2016 May;9:49-56. doi: 10.1016/j.vhri.2015.09.005. Epub 2015 Dec 4. Value Health Reg Issues. 2016. PMID: 27881259 Free article. Review.

8

Metabolic Disorders, Osteoporosis and Fracture Risk in Asia: A Systematic Review.

Sugimoto T, Sato M, Dehle FC, Brnabic AJ, Weston AR, Burge RT. Sugimoto T, et al. Among authors: brnabic aj. Value Health. 2014 Nov;17(7):A772. doi: 10.1016/j.jval.2014.08.323. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202845 Free article. No abstract available.

9

Association between teriparatide treatment persistence and adherence, and fracture incidence in Taiwan: analysis using the National Health Insurance Research Database.

Chan DC, Chang CH, Lim LC, Brnabic AJM, Tsauo JY, Burge R, Hsiao FY, Jin L, Gürbüz S, Yang RS. Chan DC, et al. Among authors: brnabic ajm. Osteoporos Int. 2016 Sep;27(9):2855-2865. doi: 10.1007/s00198-016-3611-x. Epub 2016 May 12. Osteoporos Int. 2016. PMID: 27172935 Free PMC article.

10

Study description and baseline characteristics of the population enrolled in a multinational, observational study of teriparatide in postmenopausal women with osteoporosis: the Asia and Latin America Fracture Observational Study (ALAFOS).

Chen CH, Elsalmawy AH, Ish-Shalom S, Lim SJ, Al-Ali NS, Cunha-Borges JL, Yang H, Casas N, Altan L, Moll T, Gurbuz S, Brnabic AJM, Burge RT, Marin F. Chen CH, et al. Curr Med Res Opin. 2019 Jun;35(6):1041-1049. doi: 10.1080/03007995.2018.1552576. Epub 2019 Jan 3. Curr Med Res Opin. 2019. PMID: 30474449

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page